BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17626251)

  • 1. Novel initiation genes in squamous cell carcinomagenesis: a role for substrate-specific ubiquitylation in the control of cell survival.
    Albor A; Kulesz-Martin M
    Mol Carcinog; 2007 Aug; 46(8):585-90. PubMed ID: 17626251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.
    Albor A; El-Hizawi S; Horn EJ; Laederich M; Frosk P; Wrogemann K; Kulesz-Martin M
    J Biol Chem; 2006 Sep; 281(35):25850-66. PubMed ID: 16816390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties.
    Horn EJ; Albor A; Liu Y; El-Hizawi S; Vanderbeek GE; Babcock M; Bowden GT; Hennings H; Lozano G; Weinberg WC; Kulesz-Martin M
    Carcinogenesis; 2004 Feb; 25(2):157-67. PubMed ID: 14578165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes.
    Liu Y; Lagowski JP; Gao S; Raymond JH; White CR; Kulesz-Martin MF
    J Invest Dermatol; 2010 May; 130(5):1384-90. PubMed ID: 20054338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis.
    Bischof O; Schwamborn K; Martin N; Werner A; Sustmann C; Grosschedl R; Dejean A
    Mol Cell; 2006 Jun; 22(6):783-794. PubMed ID: 16793547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMO E3 Ligase PIASy Mediates High Glucose-Induced Activation of NF-
    Huang W; Liang Y; Dong J; Zhou L; Gao C; Jiang C; Chen M; Long Y; Xu Y
    Mediators Inflamm; 2017; 2017():1685194. PubMed ID: 29038616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.
    Luo Q; Wu X; Nan Y; Chang W; Zhao P; Zhang Y; Su D; Liu Z
    Cell Rep; 2020 Jan; 30(1):98-111.e5. PubMed ID: 31914402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.
    Mabb AM; Wuerzberger-Davis SM; Miyamoto S
    Nat Cell Biol; 2006 Sep; 8(9):986-93. PubMed ID: 16906147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SseK3 Is a Salmonella Effector That Binds TRIM32 and Modulates the Host's NF-κB Signalling Activity.
    Yang Z; Soderholm A; Lung TW; Giogha C; Hill MM; Brown NF; Hartland E; Teasdale RD
    PLoS One; 2015; 10(9):e0138529. PubMed ID: 26394407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
    Ihara M; Yamamoto H; Kikuchi A
    Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM32 protein sensitizes cells to tumor necrosis factor (TNFα)-induced apoptosis via its RING domain-dependent E3 ligase activity against X-linked inhibitor of apoptosis (XIAP).
    Ryu YS; Lee Y; Lee KW; Hwang CY; Maeng JS; Kim JH; Seo YS; You KH; Song B; Kwon KS
    J Biol Chem; 2011 Jul; 286(29):25729-38. PubMed ID: 21628460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SYT-SSX1 (synovial sarcoma translocated) regulates PIASy ligase activity to cause overexpression of NCOA3 protein.
    Sun Y; Perera J; Rubin BP; Huang J
    J Biol Chem; 2011 May; 286(21):18623-32. PubMed ID: 21454665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIASy stimulates HIF1α SUMOylation and negatively regulates HIF1α activity in response to hypoxia.
    Kang X; Li J; Zou Y; Yi J; Zhang H; Cao M; Yeh ET; Cheng J
    Oncogene; 2010 Oct; 29(41):5568-78. PubMed ID: 20661221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
    Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
    Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIASy-mediated sumoylation of SREBP1c regulates hepatic lipid metabolism upon fasting signaling.
    Lee GY; Jang H; Lee JH; Huh JY; Choi S; Chung J; Kim JB
    Mol Cell Biol; 2014 Mar; 34(6):926-38. PubMed ID: 24379443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP-1 transcriptional activity is regulated by sumoylation upon heat shock.
    Martin N; Schwamborn K; Schreiber V; Werner A; Guillier C; Zhang XD; Bischof O; Seeler JS; Dejean A
    EMBO J; 2009 Nov; 28(22):3534-48. PubMed ID: 19779455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger.
    Deng Z; Wan M; Sui G
    Mol Cell Biol; 2007 May; 27(10):3780-92. PubMed ID: 17353273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-proteolytic ubiquitination of OTULIN regulates NF-κB signaling pathway.
    Zhao M; Song K; Hao W; Wang L; Patil G; Li Q; Xu L; Hua F; Fu B; Schwamborn JC; Dorf ME; Li S
    J Mol Cell Biol; 2020 Apr; 12(3):163-175. PubMed ID: 31504727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROCK2/ras
    Masre SF; Rath N; Olson MF; Greenhalgh DA
    Oncogene; 2017 May; 36(18):2529-2542. PubMed ID: 27991921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide destabilizes Pias3 and regulates sumoylation.
    Qu J; Liu GH; Wu K; Han P; Wang P; Li J; Zhang X; Chen C
    PLoS One; 2007 Oct; 2(10):e1085. PubMed ID: 17987106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.